Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks

Sarah E. Henson; Shih Chang Tsai; Cindy Sue Malone; Shahe V. Soghomonian; Yan Ouyang; Randolph Wall; York Marahrens; Michael A. Teitell

doi:10.1016/j.mrfmmm.2006.06.016

Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks

Sarah E. Henson, Shih Chang Tsai, Cindy Sue Malone, Shahe V. Soghomonian, Yan Ouyang, Randolph Wall, York Marahrens, Michael A. Teitell

Genetics, Cell Biology and Development (CBS)

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Pir51, a protein of unknown function that interacts with Rad51, was identified in a screen for genes that were highly expressed in aggressive mantle cell lymphoma (MCL) versus indolent small lymphocytic lymphoma (SLL) patient samples. We show that Pir51 is a nuclear protein expressed in a variety of cell types and that its expression is regulated during the cell cycle in a pattern nearly identical to Rad51. Also similar to Rad51, Pir51 levels did not change in response to a variety of DNA damaging agents. siRNA depletion of Pir51 did not reduce homologous recombination repair (HRR), but sensitized cells to mitomycin C (MMC)-induced DNA crosslinking and resulted in elevated levels of double-strand breaks (DSBs) in metaphase chromosome spreads and reduced colony formation. Therefore, Pir51 maintains genomic integrity and potentially connects the early response to DNA crosslinks, orchestrated by the ATR kinase and Fanconi Anemia (FA) proteins, to later stages of Rad51-dependent repair. Our results provide the first example of a Rad51-binding protein that influences DNA crosslink repair without affecting homologous recombination repair.

Original language	English (US)
Pages (from-to)	113-124
Number of pages	12
Journal	Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume	601
Issue number	1-2
DOIs	https://doi.org/10.1016/j.mrfmmm.2006.06.016
State	Published - Oct 10 2006

Bibliographical note

Funding Information:
We thank Maria Jasin (Memorial Sloan Kettering Cancer Center) for providing p59xDR-GFP6 and pCBASce constructs for HRR assays, the UCLA flow cytometry facility, Francesca M. Fike for excellent technical assistance, Robert Schiestl and Jennifer Salstrom for comments on the manuscript, and members of the Wall, Marahrens and Teitell labs for many helpful discussions. This work was supported by NIH grants GM40185 (R.W.), CA85841 (R.W.), HD41451 (Y.M.), CA90571 (M.A.T) and CA107300 (M.A.T). S.E.H. was supported by USPHS Award GM07185. The Teitell lab is also supported by CMISE, a NASA URETI Institute (NCC 201364) and M.A.T. is a Scholar of the Leukemia and Lymphoma Society.

Keywords

Cancer
Cell cycle
DNA repair
Pir51
Rad51

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.mrfmmm.2006.06.016

Find It

Find It at U of M Libraries

Cite this

Henson, S. E., Tsai, S. C., Malone, C. S., Soghomonian, S. V., Ouyang, Y., Wall, R., Marahrens, Y., & Teitell, M. A. (2006). Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 601(1-2), 113-124. https://doi.org/10.1016/j.mrfmmm.2006.06.016

Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks. / Henson, Sarah E.; Tsai, Shih Chang; Malone, Cindy Sue et al.
In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 601, No. 1-2, 10.10.2006, p. 113-124.

Research output: Contribution to journal › Article › peer-review

Henson, SE, Tsai, SC, Malone, CS, Soghomonian, SV, Ouyang, Y, Wall, R, Marahrens, Y & Teitell, MA 2006, 'Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks', Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 601, no. 1-2, pp. 113-124. https://doi.org/10.1016/j.mrfmmm.2006.06.016

@article{84707fd6a672423da8c619b47be282db,

title = "Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks",

abstract = "Pir51, a protein of unknown function that interacts with Rad51, was identified in a screen for genes that were highly expressed in aggressive mantle cell lymphoma (MCL) versus indolent small lymphocytic lymphoma (SLL) patient samples. We show that Pir51 is a nuclear protein expressed in a variety of cell types and that its expression is regulated during the cell cycle in a pattern nearly identical to Rad51. Also similar to Rad51, Pir51 levels did not change in response to a variety of DNA damaging agents. siRNA depletion of Pir51 did not reduce homologous recombination repair (HRR), but sensitized cells to mitomycin C (MMC)-induced DNA crosslinking and resulted in elevated levels of double-strand breaks (DSBs) in metaphase chromosome spreads and reduced colony formation. Therefore, Pir51 maintains genomic integrity and potentially connects the early response to DNA crosslinks, orchestrated by the ATR kinase and Fanconi Anemia (FA) proteins, to later stages of Rad51-dependent repair. Our results provide the first example of a Rad51-binding protein that influences DNA crosslink repair without affecting homologous recombination repair.",

keywords = "Cancer, Cell cycle, DNA repair, Pir51, Rad51",

author = "Henson, {Sarah E.} and Tsai, {Shih Chang} and Malone, {Cindy Sue} and Soghomonian, {Shahe V.} and Yan Ouyang and Randolph Wall and York Marahrens and Teitell, {Michael A.}",

note = "Funding Information: We thank Maria Jasin (Memorial Sloan Kettering Cancer Center) for providing p59xDR-GFP6 and pCBASce constructs for HRR assays, the UCLA flow cytometry facility, Francesca M. Fike for excellent technical assistance, Robert Schiestl and Jennifer Salstrom for comments on the manuscript, and members of the Wall, Marahrens and Teitell labs for many helpful discussions. This work was supported by NIH grants GM40185 (R.W.), CA85841 (R.W.), HD41451 (Y.M.), CA90571 (M.A.T) and CA107300 (M.A.T). S.E.H. was supported by USPHS Award GM07185. The Teitell lab is also supported by CMISE, a NASA URETI Institute (NCC 201364) and M.A.T. is a Scholar of the Leukemia and Lymphoma Society.",

year = "2006",

month = oct,

day = "10",

doi = "10.1016/j.mrfmmm.2006.06.016",

language = "English (US)",

volume = "601",

pages = "113--124",

journal = "Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis",

issn = "0027-5107",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks

AU - Henson, Sarah E.

AU - Tsai, Shih Chang

AU - Malone, Cindy Sue

AU - Soghomonian, Shahe V.

AU - Ouyang, Yan

AU - Wall, Randolph

AU - Marahrens, York

AU - Teitell, Michael A.

N1 - Funding Information: We thank Maria Jasin (Memorial Sloan Kettering Cancer Center) for providing p59xDR-GFP6 and pCBASce constructs for HRR assays, the UCLA flow cytometry facility, Francesca M. Fike for excellent technical assistance, Robert Schiestl and Jennifer Salstrom for comments on the manuscript, and members of the Wall, Marahrens and Teitell labs for many helpful discussions. This work was supported by NIH grants GM40185 (R.W.), CA85841 (R.W.), HD41451 (Y.M.), CA90571 (M.A.T) and CA107300 (M.A.T). S.E.H. was supported by USPHS Award GM07185. The Teitell lab is also supported by CMISE, a NASA URETI Institute (NCC 201364) and M.A.T. is a Scholar of the Leukemia and Lymphoma Society.

PY - 2006/10/10

Y1 - 2006/10/10

N2 - Pir51, a protein of unknown function that interacts with Rad51, was identified in a screen for genes that were highly expressed in aggressive mantle cell lymphoma (MCL) versus indolent small lymphocytic lymphoma (SLL) patient samples. We show that Pir51 is a nuclear protein expressed in a variety of cell types and that its expression is regulated during the cell cycle in a pattern nearly identical to Rad51. Also similar to Rad51, Pir51 levels did not change in response to a variety of DNA damaging agents. siRNA depletion of Pir51 did not reduce homologous recombination repair (HRR), but sensitized cells to mitomycin C (MMC)-induced DNA crosslinking and resulted in elevated levels of double-strand breaks (DSBs) in metaphase chromosome spreads and reduced colony formation. Therefore, Pir51 maintains genomic integrity and potentially connects the early response to DNA crosslinks, orchestrated by the ATR kinase and Fanconi Anemia (FA) proteins, to later stages of Rad51-dependent repair. Our results provide the first example of a Rad51-binding protein that influences DNA crosslink repair without affecting homologous recombination repair.

AB - Pir51, a protein of unknown function that interacts with Rad51, was identified in a screen for genes that were highly expressed in aggressive mantle cell lymphoma (MCL) versus indolent small lymphocytic lymphoma (SLL) patient samples. We show that Pir51 is a nuclear protein expressed in a variety of cell types and that its expression is regulated during the cell cycle in a pattern nearly identical to Rad51. Also similar to Rad51, Pir51 levels did not change in response to a variety of DNA damaging agents. siRNA depletion of Pir51 did not reduce homologous recombination repair (HRR), but sensitized cells to mitomycin C (MMC)-induced DNA crosslinking and resulted in elevated levels of double-strand breaks (DSBs) in metaphase chromosome spreads and reduced colony formation. Therefore, Pir51 maintains genomic integrity and potentially connects the early response to DNA crosslinks, orchestrated by the ATR kinase and Fanconi Anemia (FA) proteins, to later stages of Rad51-dependent repair. Our results provide the first example of a Rad51-binding protein that influences DNA crosslink repair without affecting homologous recombination repair.

KW - Cancer

KW - Cell cycle

KW - DNA repair

KW - Pir51

KW - Rad51

UR - http://www.scopus.com/inward/record.url?scp=33749658772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749658772&partnerID=8YFLogxK

U2 - 10.1016/j.mrfmmm.2006.06.016

DO - 10.1016/j.mrfmmm.2006.06.016

M3 - Article

C2 - 16920159

AN - SCOPUS:33749658772

SN - 0027-5107

VL - 601

SP - 113

EP - 124

JO - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

JF - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

IS - 1-2

ER -

Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this